Home›Companies›Biotech & Pharma›Infinant Health

Infinant Health, Inc.

Makes infant probiotic products for parents and develops a treatment for premature babies.

Updated Nov 10, 2026·Latest SEC filing Jun 8, 2026·Suggest an edit

About Infinant Health

Infinant Health is a private company based in Sacramento, California. It has reported $39,247,552 raised in one offering on Form D since June 2026. Its chief executive is Michael Johnson.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 21, 2026Jun 8, 2026$39,247,552of $118.2M target29$1.3MEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Infinant Health's Form D filed Jun 8, 2026.

Michael Johnson
Michael Johnson
Chief Executive Officer and director
ML
Mike Liang
Director
Amanda Birdsey-Benson
Amanda Birdsey-Benson
Independent Board Member
RW
Roger Wyse
Director
Katharine Knobil
Katharine Knobil
Scientific Advisor and director

Sources

  1. SECInfinant Health, Inc. filing history
  2. CompanyOur Teams
  3. PressEvivo infant probiotic release